CHIMERIC ANTIGEN RECEPTOR CELL THERAPY
Disclosed herein are pharmaceutical compositions and methods comprising chimeric antigen receptor (CAR)-bearing immune effector cells such as CAR-T cells for the treatment of cancers. Sont divulguées ici des compositions pharmaceutiques et des méthodes comprenant des cellules effectrices immunitaire...
Gespeichert in:
1. Verfasser: | |
---|---|
Format: | Patent |
Sprache: | eng ; fre |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | KABAKIBI, Ayman |
description | Disclosed herein are pharmaceutical compositions and methods comprising chimeric antigen receptor (CAR)-bearing immune effector cells such as CAR-T cells for the treatment of cancers.
Sont divulguées ici des compositions pharmaceutiques et des méthodes comprenant des cellules effectrices immunitaires portant un récepteur antigénique chimérique (CAR) telles que des cellules CAR-T pour le traitement de cancers. |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2022098756A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2022098756A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2022098756A13</originalsourceid><addsrcrecordid>eNrjZFBz9vD0dQ3ydFZw9AvxdHf1UwhydXYNCPEPUnB29fFRCPFwDXIMiORhYE1LzClO5YXS3AzKbq4hzh66qQX58anFBYnJqXmpJfHh_kYGRkYGlhbmpmaOhsbEqQIASgskeg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>CHIMERIC ANTIGEN RECEPTOR CELL THERAPY</title><source>esp@cenet</source><creator>KABAKIBI, Ayman</creator><creatorcontrib>KABAKIBI, Ayman</creatorcontrib><description>Disclosed herein are pharmaceutical compositions and methods comprising chimeric antigen receptor (CAR)-bearing immune effector cells such as CAR-T cells for the treatment of cancers.
Sont divulguées ici des compositions pharmaceutiques et des méthodes comprenant des cellules effectrices immunitaires portant un récepteur antigénique chimérique (CAR) telles que des cellules CAR-T pour le traitement de cancers.</description><language>eng ; fre</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; COMPOSITIONS THEREOF ; CULTURE MEDIA ; ENZYMOLOGY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; MICROBIOLOGY ; MICROORGANISMS OR ENZYMES ; MUTATION OR GENETIC ENGINEERING ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS ; SPIRITS ; VINEGAR ; WINE</subject><creationdate>2022</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220512&DB=EPODOC&CC=WO&NR=2022098756A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220512&DB=EPODOC&CC=WO&NR=2022098756A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>KABAKIBI, Ayman</creatorcontrib><title>CHIMERIC ANTIGEN RECEPTOR CELL THERAPY</title><description>Disclosed herein are pharmaceutical compositions and methods comprising chimeric antigen receptor (CAR)-bearing immune effector cells such as CAR-T cells for the treatment of cancers.
Sont divulguées ici des compositions pharmaceutiques et des méthodes comprenant des cellules effectrices immunitaires portant un récepteur antigénique chimérique (CAR) telles que des cellules CAR-T pour le traitement de cancers.</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>COMPOSITIONS THEREOF</subject><subject>CULTURE MEDIA</subject><subject>ENZYMOLOGY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MICROORGANISMS OR ENZYMES</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</subject><subject>SPIRITS</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2022</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZFBz9vD0dQ3ydFZw9AvxdHf1UwhydXYNCPEPUnB29fFRCPFwDXIMiORhYE1LzClO5YXS3AzKbq4hzh66qQX58anFBYnJqXmpJfHh_kYGRkYGlhbmpmaOhsbEqQIASgskeg</recordid><startdate>20220512</startdate><enddate>20220512</enddate><creator>KABAKIBI, Ayman</creator><scope>EVB</scope></search><sort><creationdate>20220512</creationdate><title>CHIMERIC ANTIGEN RECEPTOR CELL THERAPY</title><author>KABAKIBI, Ayman</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2022098756A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2022</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>COMPOSITIONS THEREOF</topic><topic>CULTURE MEDIA</topic><topic>ENZYMOLOGY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MICROORGANISMS OR ENZYMES</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</topic><topic>SPIRITS</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>KABAKIBI, Ayman</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>KABAKIBI, Ayman</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>CHIMERIC ANTIGEN RECEPTOR CELL THERAPY</title><date>2022-05-12</date><risdate>2022</risdate><abstract>Disclosed herein are pharmaceutical compositions and methods comprising chimeric antigen receptor (CAR)-bearing immune effector cells such as CAR-T cells for the treatment of cancers.
Sont divulguées ici des compositions pharmaceutiques et des méthodes comprenant des cellules effectrices immunitaires portant un récepteur antigénique chimérique (CAR) telles que des cellules CAR-T pour le traitement de cancers.</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng ; fre |
recordid | cdi_epo_espacenet_WO2022098756A1 |
source | esp@cenet |
subjects | BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPIRITS VINEGAR WINE |
title | CHIMERIC ANTIGEN RECEPTOR CELL THERAPY |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T20%3A09%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=KABAKIBI,%20Ayman&rft.date=2022-05-12&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2022098756A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |